Olle Ericsson

Olle Ericsson is an experienced leader in the field of molecular medicine and diagnostics, currently serving as Founder and CEO of Moleculent since September 2021. Previously, Olle held the position of Managing Director for Vanadis Diagnostics at PerkinElmer, guiding the launch of a groundbreaking non-invasive prenatal testing system. Olle founded and led Vanadis Diagnostics from December 2013 to December 2015, focusing on accessible high-performance prenatal screening. Earlier roles include Founder and CEO of Halo Genomics, where Olle oversaw the company's growth and eventual acquisition by Agilent Technologies, along with a tenure as Marketing Director for DNA Sequencing at Agilent. Olle has a robust academic background with a PhD in Molecular Medicine and multiple degrees from Uppsala University and the University of Sydney.